Heron Therapeutics | HRTX - Loan Capital


Heron Therapeutics reported $140.64M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
ALKERMES USD 285.82M 639K Sep/2024
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
ANI Pharmaceuticals USD 291.84M 5.84M Dec/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Eisai JPY 134.77B 12M Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Heron Therapeutics USD 140.64M 975K Dec/2025
Insmed USD 540.96M 1.24M Dec/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Merck USD 39.97B 6B Sep/2025
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Omeros USD 403.72M 27.2M Jun/2024
Pacira USD 372.19M 4.53M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Surmodics USD 29.55M 30K Sep/2024
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Veracyte USD 0 0 Mar/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025